Valacyclovir for Prevention of Recurrent Herpes Labialis: 2 Double-Blind, Placebo-Controlled Studies

Article Type
Changed
Thu, 01/10/2019 - 11:58
Display Headline
Valacyclovir for Prevention of Recurrent Herpes Labialis: 2 Double-Blind, Placebo-Controlled Studies

Article PDF
Author and Disclosure Information

Baker D, Eisen D

Issue
Cutis - 71(3)
Publications
Topics
Page Number
239-242
Sections
Author and Disclosure Information

Baker D, Eisen D

Author and Disclosure Information

Baker D, Eisen D

Article PDF
Article PDF

Issue
Cutis - 71(3)
Issue
Cutis - 71(3)
Page Number
239-242
Page Number
239-242
Publications
Publications
Topics
Article Type
Display Headline
Valacyclovir for Prevention of Recurrent Herpes Labialis: 2 Double-Blind, Placebo-Controlled Studies
Display Headline
Valacyclovir for Prevention of Recurrent Herpes Labialis: 2 Double-Blind, Placebo-Controlled Studies
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Selecting Topical and Systemic Agents for Recurrent Aphthous Stomatitis (See Letter to the Editor. 2002;70:275.)

Article Type
Changed
Thu, 01/10/2019 - 11:52
Display Headline
Selecting Topical and Systemic Agents for Recurrent Aphthous Stomatitis (See Letter to the Editor. 2002;70:275.)
Article PDF
Author and Disclosure Information

 

Eisen D, Lynch DP

Issue
Cutis - 68(3)
Publications
Page Number
201-206
Author and Disclosure Information

 

Eisen D, Lynch DP

Author and Disclosure Information

 

Eisen D, Lynch DP

Article PDF
Article PDF
Issue
Cutis - 68(3)
Issue
Cutis - 68(3)
Page Number
201-206
Page Number
201-206
Publications
Publications
Article Type
Display Headline
Selecting Topical and Systemic Agents for Recurrent Aphthous Stomatitis (See Letter to the Editor. 2002;70:275.)
Display Headline
Selecting Topical and Systemic Agents for Recurrent Aphthous Stomatitis (See Letter to the Editor. 2002;70:275.)
Disallow All Ads
Article PDF Media

Efficacy and Safety of Terbinafine 1% Solution in the Treatment of Interdigital Tinea Pedis and Tinea Corporis or Tinea Cruris

Article Type
Changed
Thu, 01/10/2019 - 11:50
Display Headline
Efficacy and Safety of Terbinafine 1% Solution in the Treatment of Interdigital Tinea Pedis and Tinea Corporis or Tinea Cruris

Article PDF
Author and Disclosure Information

Lebwohl M, Elewski B, Eisen D, Savin RC, The Terbinafine 1% Solution Group (SFF-351)

Issue
Cutis - 67(3)
Publications
Topics
Page Number
261-266
Sections
Author and Disclosure Information

Lebwohl M, Elewski B, Eisen D, Savin RC, The Terbinafine 1% Solution Group (SFF-351)

Author and Disclosure Information

Lebwohl M, Elewski B, Eisen D, Savin RC, The Terbinafine 1% Solution Group (SFF-351)

Article PDF
Article PDF

Issue
Cutis - 67(3)
Issue
Cutis - 67(3)
Page Number
261-266
Page Number
261-266
Publications
Publications
Topics
Article Type
Display Headline
Efficacy and Safety of Terbinafine 1% Solution in the Treatment of Interdigital Tinea Pedis and Tinea Corporis or Tinea Cruris
Display Headline
Efficacy and Safety of Terbinafine 1% Solution in the Treatment of Interdigital Tinea Pedis and Tinea Corporis or Tinea Cruris
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media